Rekombinanter GDF15 (Visugromab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter GDF15 (Visugromab Biosimilar) Antikörper (ABIN7598095)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Güteklasse
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Research Grade Visugromab Biosimilar Antibody
-
Spezifität
- PLAB, Placental bone morphogenetic protein, MIC1, NRG-1, PTGFB, NSAID-regulated gene 1 protein, GDF15, NAG-1, MIC-1, Prostate differentiation factor, NSAID-activated gene 1 protein, Growth/differentiation factor 15, Macrophage inhibitory cytokine 1, Placental TGF-beta, GDF-15, PDF
-
Aufreinigung
- Protein A or G purified from cell culture supernatant.
-
Reinheit
- >95 % by SDS-PAGE.
-
Isotyp
- IgG4 kappa
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Haltbarkeit
- 12 months
-
-
- GDF15 (Visugromab Biosimilar)
-
Andere Bezeichnung
- Visugromab Biosimilar
-
Substanzklasse
- Biosimilar
-
Hintergrund
- PLAB, Placental bone morphogenetic protein, MIC1, NRG-1, PTGFB, NSAID-regulated gene 1 protein, GDF15, NAG-1, MIC-1, Prostate differentiation factor, NSAID-activated gene 1 protein, Growth/differentiation factor 15, Macrophage inhibitory cytokine 1, Placental TGF-beta, GDF-15, PDF
-
UniProt
- Q99988
-
CAS-Nummer
- 2556646-63-8
Target
-